Form 4: Vita Coco Director Ira Liran Sells Shares Under 10b5-1 Trading Plan

Director Ira Liran sold shares of Vita Coco Company, Inc. on February 12 and 13, 2025, under a pre-arranged Rule 10b5-1 trading plan.

Summary

• Ira Liran, a director of Vita Coco Company, Inc., reported the sale of common stock on February 12 and 13, 2025.
• The sales were executed under a Rule 10b5-1 trading plan.
• On February 12, 2025, 300 shares were sold at a weighted average price of $40.02, with prices ranging from $40.00 to $40.04.
• On February 13, 2025, 18,892 shares were sold at a weighted average price of $40.096, with prices ranging from $40.00 to $40.30.
• Following these transactions, Ira Liran directly owns 635,055 shares and indirectly owns 834,537 shares through the Ira Liran 2012 Family Trust.

Sentiment

Score: 5

Explanation: The document is a standard regulatory filing related to share sales by a company director. It doesn't inherently convey positive or negative sentiment.

Industry Context

Sales by company directors are a normal part of corporate governance. The use of a 10b5-1 trading plan suggests the sales were pre-planned and not based on inside information.

Comparison to Industry Standards

• Director share sales are common across publicly traded companies.
• Rule 10b5-1 trading plans are a standard method for insiders to sell shares without raising concerns about insider trading.
• Comparable companies such as National Beverage Corp. (FIZZ) and Keurig Dr Pepper (KDP) also see regular Form 4 filings from their directors and officers.

Stakeholder Impact

• The share sales could have a minor impact on shareholders, potentially creating downward pressure on the stock price in the short term.
• The use of a 10b5-1 plan mitigates concerns about insider trading, reassuring stakeholders.

Key Dates